A Retrospective Cohort Study of Multiple Immune-Related Adverse Events and Clinical Outcomes Among Patients With Cancer Receiving Immune Checkpoint Inhibitors

BACKGROUND AND OBJECTIVES: Immune checkpoint inhibitors (ICIs) are effective in various types of cancer and cause immune-related adverse events (irAEs). The occurrence of irAEs is associated with improved survival outcome. We investigated the association between the occurrence of irAEs and overall s...

Descripción completa

Detalles Bibliográficos
Autores principales: Hata, Hiroki, Matsumura, Chikako, Chisaki, Yugo, Nishioka, Kae, Tokuda, Misaki, Miyagi, Kazuyo, Suizu, Tomoki, Yano, Yoshitaka
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9583223/
https://www.ncbi.nlm.nih.gov/pubmed/36254804
http://dx.doi.org/10.1177/10732748221130576

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9583223/
https://www.ncbi.nlm.nih.gov/pubmed/36254804
http://dx.doi.org/10.1177/10732748221130576

Ejemplares similares